Literature DB >> 29806239

Use of D-dimer in oral anticoagulation therapy.

L Zhang1, Y Long2, H Xiao2, J Yang1, P Toulon3, Z Zhang1.   

Abstract

Individualized anticoagulation management and improvement of the safety and effectiveness of oral anticoagulant have always been the focus of clinicians' attention. D-dimer, a sensitive marker of thrombosis and coagulation activation, is not only traditionally used in the diagnosis of venous thromboembolism, acute aortic dissection, and disseminated intravascular coagulation but can also be used as a helpful marker in the management of oral anticoagulant, including evaluating the anticoagulation quality, predicting clinical outcomes, and determining the optimal duration and intensity of anticoagulation.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  D-dimer; anticoagulation therapy; direct oral anticoagulants; vitamin K antagonists

Year:  2018        PMID: 29806239     DOI: 10.1111/ijlh.12864

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  15 in total

Review 1.  The role of biomarkers in diagnosis of COVID-19 - A systematic review.

Authors:  Muhammed Kermali; Raveena Kaur Khalsa; Kiran Pillai; Zahra Ismail; Amer Harky
Journal:  Life Sci       Date:  2020-05-13       Impact factor: 5.037

2.  The role of biomarkers in diagnosis of COVID-19 - A systematic review.

Authors:  Muhammed Kermali; Raveena Kaur Khalsa; Kiran Pillai; Zahra Ismail; Amer Harky
Journal:  Life Sci       Date:  2020-05-13       Impact factor: 5.037

Review 3.  COVID-19 and hypertension-evidence and practical management: Guidance from the HOPE Asia Network.

Authors:  Kazuomi Kario; Yuji Morisawa; Apichard Sukonthasarn; Yuda Turana; Yook-Chin Chia; Sungha Park; Tzung-Dau Wang; Chen-Huan Chen; Jam Chin Tay; Yan Li; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-07-09       Impact factor: 3.738

4.  Elevated levels of D-dimer in patients with COVID-19: prognosis value.

Authors:  Sara Oualim; Salma Abdeladim; Amal El Ouarradi; Ilham Bensahi; Sara Hafid; Abdelhamid Naitlho; Elarbi Bouaiti; Mohamed Sabry
Journal:  Pan Afr Med J       Date:  2020-07-07

5.  Acute kidney injury in patients with severe COVID-19 in Mexico.

Authors:  Gustavo A Casas-Aparicio; Isabel León-Rodríguez; Claudia Alvarado-de la Barrera; Mauricio González-Navarro; Amy B Peralta-Prado; Yara Luna-Villalobos; Alejandro Velasco-Morales; Natalia Calderón-Dávila; Christopher E Ormsby; Santiago Ávila-Ríos
Journal:  PLoS One       Date:  2021-02-08       Impact factor: 3.240

6.  Vitamin D deficiency is associated with COVID-19 positivity and severity of the disease.

Authors:  Mustafa Demir; Fadime Demir; Hatice Aygun
Journal:  J Med Virol       Date:  2021-02-09       Impact factor: 20.693

7.  Association between renin-angiotensin-aldosterone system inhibitor treatment, neutrophil-lymphocyte ratio, D-Dimer and clinical severity of COVID-19 in hospitalized patients: a multicenter, observational study.

Authors:  Selcuk Gormez; Erkan Ekicibasi; Aleks Degirmencioglu; Ashok Paudel; Refik Erdim; Hilal Kurtoglu Gumusel; Elif Eroglu; Ibrahim Halil Tanboga; Sinan Dagdelen; Nevin Sariguzel; Ceyda Erel Kirisoglu; Burak Pamukcu
Journal:  J Hum Hypertens       Date:  2020-08-24       Impact factor: 3.012

8.  Response to "All these D-dimers in COVID-19".

Authors:  Litao Zhang
Journal:  J Thromb Haemost       Date:  2020-08       Impact factor: 16.036

9.  Response to "Uncertainties on the prognostic value of D-dimers in COVID-19 patients".

Authors:  Litao Zhang
Journal:  J Thromb Haemost       Date:  2020-07-15       Impact factor: 16.036

10.  D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19.

Authors:  Litao Zhang; Xinsheng Yan; Qingkun Fan; Haiyan Liu; Xintian Liu; Zejin Liu; Zhenlu Zhang
Journal:  J Thromb Haemost       Date:  2020-06       Impact factor: 16.036

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.